From February 5, 2024 to March 31, 2024, the company has repurchased 2,070,000 shares, representing 1.08% for CNY 12.98 million. With this, the company has completed the repurchase of 2,070,000 shares, representing 1.08% for CNY 12.98 million under the buyback announced on February 6, 2024.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.98 CNY | +1.66% | +10.22% | -28.04% |
1st Jan change | Capi. | |
---|---|---|
-28.04% | 209M | |
-0.44% | 1.45B | |
-3.32% | 1.43B | |
-5.79% | 1.21B | |
-14.59% | 899M | |
+1.72% | 480M | |
+3.85% | 440M | |
-48.41% | 369M | |
-19.75% | 356M | |
-2.93% | 213M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Tranche Update on Thalys Medical Technology Group Corporation's Equity Buyback Plan announced on February 6, 2024.